APA (7th ed.) Citation

Howell, M., Gibb, A., Radford, J., & Linton, K. (2017). Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin. British Journal of Haematology, 179(5), 841. https://doi.org/10.1111/bjh.14257

Chicago Style (17th ed.) Citation

Howell, Matthew, Adam Gibb, John Radford, and Kim Linton. "Bendamustine Can Be a Bridge to Allogeneic Transplantation in Relapsed Hodgkin Lymphoma Refractory to Brentuximab Vedotin." British Journal of Haematology 179, no. 5 (2017): 841. https://doi.org/10.1111/bjh.14257.

MLA (9th ed.) Citation

Howell, Matthew, et al. "Bendamustine Can Be a Bridge to Allogeneic Transplantation in Relapsed Hodgkin Lymphoma Refractory to Brentuximab Vedotin." British Journal of Haematology, vol. 179, no. 5, 2017, p. 841, https://doi.org/10.1111/bjh.14257.